Related by context. All words. (Click for frequent words.) 74 Quark Pharmaceuticals 72 Quark Biotech 71 Alligator Bioscience AB 71 Catalyst Biosciences 70 Elixir Pharmaceuticals 70 Agios Pharmaceuticals 70 NYSE Amex PBTH 70 Nasdaq CGEN 70 LEAD Therapeutics 69 Epitomics 69 Regado Biosciences 69 FoldRx Pharmaceuticals Inc. 69 Archemix Corp. 69 tiapamil 69 Creabilis Therapeutics 69 therapeutic monoclonal antibodies 69 Idera Pharmaceuticals 69 OTCBB PYTO 68 Adenosine Therapeutics 68 Bayhill Therapeutics 68 Regulus Therapeutics 68 Galenea 68 Taligen Therapeutics 68 Vaccinex 68 Leonard P. Shaykin 68 FoldRx 68 PsychoGenics 68 BXT # 68 Proteo 68 Repligen Corporation 68 Ceragenix 68 Scancell 67 Pervasis 67 Fovea Pharmaceuticals 67 InNexus Biotechnology 67 ImmuneRegen BioSciences Inc. 67 Alvine Pharmaceuticals 67 TRACON Pharmaceuticals 67 Amira Pharmaceuticals 67 Tezampanel 67 Xenon Pharmaceuticals 67 Ercole Biotech 67 Nastech Pharmaceutical Company 67 Chronogen 67 Syntonix Pharmaceuticals 67 Euroscreen 67 FOLOTYN ® 67 Avila Therapeutics 67 Novosom 67 Anthony Giovinazzo 67 ProLindac TM 67 Pervasis Therapeutics Inc. 67 Epiphany Biosciences 67 Immunotherapeutic 67 AB OMXS BINV 67 Inc. Nasdaq ALNY 67 OTCBB IMUC 67 NanoPass 67 Oxford Genome Sciences 67 Systemic Delivery 66 therapeutic monoclonal antibody 66 Aviptadil 66 Portola Pharmaceuticals 66 Transcept Pharmaceuticals 66 Resolvyx Pharmaceuticals 66 Epeius Biotechnologies Corporation 66 Chroma Therapeutics 66 OTCBB CVBT 66 Initiates Clinical Trial 66 BioNumerik 66 Ulrich Dauer CEO 66 IR Biosciences 66 Liprotamase 66 Monoclonal antibody 66 Cenix BioScience 66 telomerase therapeutic 66 Arno Therapeutics 66 Pepscan Therapeutics 66 rxRNA 66 EnzymeRx 66 RNA antagonists 66 Celator 66 Kerecis 66 Personalized Immunotherapy 66 Nasdaq OMER 66 Cenomed 66 Initiates Clinical 66 Cetrorelix 66 Commercialize Novel 66 Melior Discovery 66 CureDM 66 Ariadne Genomics 66 Exploit collaboration 66 Myrexis Inc. 66 OTCBB NRGX 66 ImmunoCellular Therapeutics 66 Inc. OTCBB IRBS 66 Receptos 66 Aerie Pharmaceuticals 66 Velcura 66 Debiopharm SA 66 MultiCell Technologies 66 Initiates Enrollment 66 Saegis Pharmaceuticals 66 Hybridon 66 OMRIX Biopharmaceuticals Inc. 66 KAI Pharmaceuticals Inc. 66 Vernalis plc 66 Squalamine 66 Applied NeuroSolutions 66 Fabry Disease 66 OTCBB PYTO FWB ET6 66 Reata Pharmaceuticals 66 ProFibrix 66 Viamet Pharmaceuticals 66 AMEX RGN 66 Ophthotech 66 PROLOR Biotech Inc. 66 Friedreich Ataxia FRDA 65 Virdante 65 NYSE AMEX IBIO 65 Sangamo BioSciences 65 NASDAQ ISIS 65 Nasdaq HALO 65 OTCBB CGXP 65 Ridaforolimus 65 KAI Pharmaceuticals 65 Transfection Reagent 65 Amarantus 65 Cytokine PharmaSciences 65 OTCBB HXBM developer 65 AviaraDx 65 Molecular Biometrics 65 Genotyping Test 65 lipid nanoparticle 65 Iomai Corporation 65 Tranzyme Pharma 65 Nereus Pharmaceuticals 65 acetonide FA 65 Adamis Pharmaceuticals 65 Flamel Technologies 65 Nuron Biotech 65 Kleanthis G. Xanthopoulos Ph.D. 65 Odyssey Thera 65 AtuRNAi 65 Familial Adenomatous Polyposis FAP 65 Therion Biologics Corporation 65 Therapeutic Competitors companiesandmarkets.com adEgemonye 65 AMEX REX 65 Initiates Phase II 65 Cellerant Therapeutics 65 Logical Therapeutics 65 AmpliMed 65 NASDAQ INFI 65 Epitome Biosystems 65 novel peptides 65 Genospectra 65 CyDex Pharmaceuticals Inc. 65 Prism Pharmaceuticals 65 HepaLife Technologies Inc. 65 BioLife Solutions 65 Etubics 65 glucokinase activator 65 Onconase 65 OTCBB CTIX 65 SR Pharma 65 targeted radiotherapeutic 65 Locus Pharmaceuticals 65 YONDELIS R 65 Initiates Clinical Trials 65 Genocea Biosciences 65 Aganocide ® 65 OTCBB NPHC biotechnology 65 Aradigm Corporation 65 Capsulution 65 Galderma SA 65 Silodosin 65 PharmaNova 65 Conatus Pharmaceuticals 65 Phenomix Corporation 65 Cara Therapeutics 65 PhaseBio 65 Tobira Therapeutics 65 Therapeutic Competitors Report 65 VIA Pharmaceuticals 65 Nasdaq HALO biopharmaceutical 65 NASDAQ CGEN announced 65 selective androgen receptor modulators 64 Velcura Therapeutics 64 Ore Pharmaceuticals 64 OTCBB ADXS 64 QR Pharma 64 novel immunomodulatory 64 HuMax HepC TM 64 Therapeutic Competitors Companies 64 Fresenius Biotech 64 Tibotec BVBA 64 EMD Biosciences Inc. 64 Addrenex Pharmaceuticals 64 Receives Orphan Drug Designation 64 GammaCan 64 Epizyme 64 Inc Therapeutic Competitors 64 Nasdaq ALNY 64 ActivX 64 CeNeRx BioPharma 64 Supernus Pharmaceuticals 64 EMD Biosciences 64 Initiates Phase III 64 Tikvah Therapeutics 64 DOV Pharmaceutical Inc. 64 KineMed 64 Begins Dosing 64 Othera Pharmaceuticals Inc. 64 Prana Biotechnology Limited 64 ARRY # 64 Myolimus 64 Georges Gemayel 64 Metabasis Therapeutics Inc. 64 Merrimack Pharmaceuticals 64 Arriva Pharmaceuticals 64 Potelligent Technology 64 Civacir 64 Ceflatonin R 64 Cardioxyl Pharmaceuticals 64 BioWa 64 Prometheus Laboratories 64 NovaBay Pharmaceuticals 64 Antisense Pharma GmbH 64 Pevion 64 OTCBB IBPM 64 Genaera Corporation 64 adrenergic regulation 64 BioSeek 64 pralatrexate injection folate analogue 64 VentiRx 64 RenaZorb TM 64 Intellect Neurosciences 64 hyaluronidase enzyme 64 QuatRx Pharmaceuticals 64 anti CD3 monoclonal 64 MEK inhibitor 64 Lentigen Corporation 64 PolyTherics 64 AQUA ® 64 Affimed Therapeutics AG 64 ESBATech AG 64 Chemokine Therapeutics 64 Alder Biopharmaceuticals 64 OTC BB PVCT 64 RHEI Pharmaceuticals 64 enGene 64 Inotek Pharmaceuticals Corporation 64 Pepscan 64 Ascenta Therapeutics 64 Salmedix 64 Memory MRAM 64 Cyto Pulse 64 NeuroSolutions 64 EnVivo 64 Syntonix 64 Nasdaq PARD 64 Kazumi Shiosaki 64 ERYtech 64 Quark Pharmaceuticals Inc. 64 BioSpecifics Technologies Corp. 64 adenosine A2A 64 Acuity Pharmaceuticals 64 TolerRx 64 ImmunoCellular Therapeutics Ltd. 64 IMiDs ® 64 Prima BioMed 64 Cytochroma 64 Tacere 64 Mersana Therapeutics Inc. 64 ImmunoGen Inc. 64 Presidio Pharmaceuticals 64 OPKO Health 64 Azur Pharma 64 Relypsa 64 Scil Proteins 64 oral salmon calcitonin 64 Naurex 64 Anaphore 64 AcuFocus 64 Neogenix 64 Initiate Clinical Trial 64 Locked Nucleic Acid 64 Homspera TM 64 Protalex Inc. 64 Progenics Pharmaceuticals 64 Brainstorm Cell Therapeutics 64 Elagolix 64 Brussels THR 64 deCODE chemistry 64 Viralytics 64 VentiRx Pharmaceuticals 64 AMEX ONI 64 Aeolus Pharmaceuticals 64 theranostic 64 Mersana Therapeutics 64 Molecular Templates 64 TRANSDUR ™ 64 Affibody 64 ZARS Pharma 64 Inc. Nasdaq NSTK 64 Immuron 64 IL# PE#QQR 64 mertansine 64 Xanthus Pharmaceuticals Inc. 64 Argenta Discovery 64 Completes Patient Enrollment 64 Saladax Biomedical 64 VisEn Medical 64 OTCBB VCRT 64 Intarcia 64 Vegenics 64 Auspex Pharmaceuticals 64 Leuchemix 64 Therapeutic Antibody 64 Cerimon 64 Aestus Therapeutics 63 Nasdaq RXII 63 RTP #i 63 EnVivo Pharmaceuticals 63 antisense inhibitors 63 ABI OTCBB AMAR 63 Diatos 63 IV Busulfex 63 InteKrin Therapeutics 63 Nycomed GmbH 63 THR beta agonist 63 FluoroPharma 63 Nautilus Biotech 63 Phase 2b Trial 63 Raven Biotechnologies 63 Hoyoung Huh 63 Altair Therapeutics 63 OPi 63 Cellzome 63 Curaxin 63 Kiadis 63 Xcytrin R 63 Ambrx 63 Barrier Therapeutics Inc. 63 siRNA therapeutics 63 Addrenex 63 KuDOS 63 VIRxSYS 63 Generex Biotechnology 63 Nasdaq IDRA 63 Cellgate Inc. 63 Helix BioMedix Inc. 63 Robert L. Bratzler 63 PDE4 inhibitor 63 Napo Pharmaceuticals 63 Alseres Pharmaceuticals Inc. 63 EntreMed Inc. 63 AskBio 63 Chipscreen 63 Meritage Pharma 63 Stanate R 63 Idenix Pharmaceuticals 63 Abstract Accepted 63 PNT# 63 Sunshine Biopharma 63 TransPharma 63 Viacell 63 Receives Approvable Letter 63 Daniel Tasse 63 PHX# 63 Synergy Pharmaceuticals 63 Emisphere Technologies 63 Initiates Dosing 63 botanical therapeutics 63 MBRX 63 Akebia Therapeutics 63 Nasdaq ACHN 63 huC# DM4 63 KYTHERA Biopharmaceuticals Inc. 63 Alnara Pharmaceuticals 63 Dynogen 63 Zelos Therapeutics 63 Taiho Pharmaceutical 63 DermTech 63 Kirsten Drejer 63 Power3 Medical 63 VasoGenix Pharmaceuticals 63 t2cure GmbH 63 SOLVAY PHARMACEUTICALS 63 Pharmion Corporation 63 Drug Candidate 63 PhotoThera 63 kidney urologic 63 Expression Genetics 63 Cerus Corporation 63 immatics 63 Protein Polymer Technologies 63 Receives Milestone Payment 63 AVXL 63 Chiral Quest 63 Announces Poster Presentations 63 OTCBB CHKT 63 OTCBB FCSC 63 Genetic Therapy 63 Albugon 63 Ltd. OTCBB IMUC 63 ACTCellerate 63 IR BioSciences Holdings 63 Lung Rx 63 Zentaris 63 Mipomersen 63 OncoMed 63 FORMA Therapeutics 63 DiaKine 63 Bertek Pharmaceuticals 63 ViaCyte 63 platform HDL Mimetic 63 Omeros Corporation 63 Alnylam Pharmaceuticals Nasdaq ALNY 63 Nasdaq IDRA today 63 Affimed 63 2 inhibitor CYT# 63 ProNAi 63 uricase 63 Akela Pharma Inc. 63 GeneMax 63 Procognia 63 Surface Logix 63 InterfeRx TM 63 Immunotope 63 Teikoku Pharma USA 63 PhytoMedical Technologies Inc. 63 Amunix 63 Nasdaq KOSN 63 OGeS 63 Intravenous Human 63 NKT Therapeutics 63 Nitazoxanide 63 EVIZON TM 63 PluriCells 63 platinum chemotherapeutic 63 EGIR 63 HemoGenix 63 FASgen 63 Ibis Biosciences 63 Idun Pharmaceuticals 63 Agenus 63 Nasdaq LEXG 63 Nanobiotix 63 StromaCel Inc. 63 GendeLLindheim BioCom Partners 63 ASX BLT 63 Kuvan R 63 Calistoga Pharmaceuticals 63 Versartis 63 Glufosfamide 63 ImQuest Pharmaceuticals 63 candidate deforolimus 63 Nasdaq IDIX biopharmaceutical 63 IntegraGen 63 Presents Preclinical Data 63 Lexicon Pharmaceuticals 63 Alton Boynton 63 DiscoveRx 63 POTELLIGENT ® 63 stable nucleic acid 63 Kathleen Danenberg 63 AVANT Immunotherapeutics 63 Aduro BioTech 63 small molecule agonists 63 vaccine GRNVAC1 63 Iloperidone 63 TransTech Pharma 63 Mersana 63 Oasmia 63 Files IND 63 Cylene Pharmaceuticals 63 Affitech AS 63 Myocet 63 Biotica 63 OncoMethylome 63 OncoMethylome Sciences 63 Factor VIIa 63 Sorrento Therapeutics 63 CIMYM 63 Ception Therapeutics 63 Safinamide 63 Aegera 63 Harbor BioSciences 63 ASX PGL 63 CysDisplay R 63 Shai Novik President 63 Symphogen 63 Handok Pharmaceuticals 63 OMRIX 63 ImmunoVaccine Technologies 63 Sapphire Therapeutics 63 VitiGam 63 Phytomedics Inc. 63 Corixa Corporation 63 Tyrian Diagnostics 63 Inc. OTCBB VODG 62 ReVision Optics 62 NovaDel Pharma 62 Neurome 62 Intellikine 62 prostone 62 CAMBRIDGE Mass. Alnylam Pharmaceuticals 62 Neurim Pharmaceuticals 62 YONDELIS 62 Monoclonal Antibody 62 Presents Preclinical 62 Paratek Pharmaceuticals Inc. 62 IMiDs R 62 Luteinizing Hormone Releasing Hormone 62 selective immunoproteasome inhibitor 62 Nasdaq IMGN 62 novel peptide 62 Phase 2a Clinical Trial 62 arGentis 62 SinuNase ™ 62 histone deacetylase inhibitor 62 CDP# 62 Present Preclinical Data 62 Advancing Drugs 62 Nasdaq PGNX 62 Combination REOLYSIN R 62 Panacea Pharmaceuticals 62 Inc. AMEX YMI 62 Viamet 62 Adnan Mjalli 62 LibiGel ® 62 ImaginAb 62 NASDAQ EPIX 62 ELADUR ™ 62 Afferent Pharmaceuticals 62 Wellstat 62 ORTHOCON 62 Norgine BV 62 acne impetigo 62 Cempra Pharmaceuticals 62 telomerase activators 62 include PLX IBD 62 Nipent R 62 Prodarsan R 62 Aerovance 62 Juvaris BioTherapeutics 62 Oxxon 62 Piramed 62 DP VPA 62 Diffusion Pharmaceuticals 62 XenoTech 62 GeneICE 62 Dynepo TM 62 Atugen 62 elbion 62 Excaliard 62 vascular disrupting agents 62 treat gastrointestinal disorders 62 Protagen 62 EPIX Pharmaceuticals Inc. 62 anticancer therapeutics 62 humanized monoclonal 62 Tacere Therapeutics 62 PF # [002] 62 Synosia Therapeutics 62 product platforms AZX# 62 immunotherapeutics 62 Preclinical Development 62 reslizumab 62 OTCQB CTIX 62 Modrenal R 62 Nereus Pharmaceuticals Inc. 62 TransMolecular 62 oral ghrelin agonist 62 Cascade LifeSciences 62 M.D. Ph.D. 62 Cx# [002] 62 Small Molecule 62 novel anti infective 62 TOPICA 62 Metabasis Therapeutics 62 molecular imaging radiopharmaceutical 62 Avian Transgenic Technology 62 Novasys Medical 62 Lightlake Therapeutics 62 Seikagaku 62 RNAi Therapeutics 62 NASDAQ LGND 62 Peptimmune 62 Adlyfe 62 Onalta 62 CD# CEA 62 OTCBB MCET 62 Juergen Engel Ph.D. 62 tkRNAi 62 Helsinn Healthcare 62 Reports Preclinical Data 62 Prolor Biotech 62 Avecia Biotechnology 62 Vitamin D analogue 62 Mesoblast Limited ASX MSB 62 VivaGel ™ 62 LEVADEX ™ 62 Campath ® 62 initiated Phase 1b 62 Nasdaq PANC 62 Frankfurt XMP 62 Ron Bentsur 62 Decision Biomarkers 62 Paladin Labs 62 ospemifene 62 Anidulafungin 62 HCV protease inhibitor 62 Onalta TM 62 TSX CTI 62 OTCBB QTXB 62 Therapeutic Vaccine 62 Avidex 62 Response Genetics 62 Cerashield ™ 62 Sunesis Pharmaceuticals 62 JAK2 Inhibitor 62 Thrombin topical Recombinant 62 Ucyclyd Pharma Inc. 62 PrevOnco 62 Nasdaq MITI biopharmaceutical 62 Enters Into Collaboration 62 Cabrellis Pharmaceuticals 62 Peregrine Pharmaceuticals 62 Aegera Therapeutics 62 Halozyme Therapeutics 62 OTCBB IMNR 62 JCR Pharmaceuticals 62 Millennium Biotechnologies 62 Xytis 62 Obecure 62 Receive Milestone Payment 62 UltiMAb 62 Gentel Biosciences 62 IAP inhibitors 62 Tigris Pharmaceuticals 62 Scynexis 62 Viprovex TM 62 Vaughn M. Kailian 62 CeNeRx 62 NYSE Amex AEN 62 RayBiotech 62 Recombinant Human 62 FzioMed 62 thiazolides 62 Inc. Nasdaq COLY 62 Cerimon Pharmaceuticals 62 commercialize Aganocides 62 TapImmune 62 InterfeRx 62 NOXXON 62 Ardea Biosciences 62 Inhalation Solution 62 Accentia Biopharmaceuticals 62 Progenika 62 Syndax 62 InVasc 62 Arete Therapeutics 62 Kissei Pharmaceutical 62 Circ Pharma 62 Falk Pharma 62 delivers fluocinolone acetonide FA 62 MOVIPREP R 62 immunotherapeutic vaccine 62 Amex PTN 62 Enzo Therapeutics 62 OTCBB CHKT biotechnology 62 Trophos 62 Therion Biologics 62 AC Immune 62 PeriCor Therapeutics 62 Verus Pharmaceuticals 62 ATL# [002] 62 BrainCells 62 RECOTHROM ® 62 please visit www.metabolon.com 62 Panzem R 62 China Aoxing Pharmaceutical 62 Sequella 62 ChondroGene 62 Metabolex 62 mGluR4 PAM 62 Eric von Hofe 62 Calibrant Biosystems 62 liposomal delivery 62 cMET 62 Bone Biologics 62 miRagen Therapeutics 62 ZFP Therapeutics 62 Alnylam Pharmaceuticals Inc 62 Trubion Pharma 62 Celsion Corporation 62 Mymetics Corporation 62 Ostabolin C TM 62 Selexis 62 ERYtech Pharma 62 Agendia BV 62 Coronado Biosciences 62 APT Pharmaceuticals 62 OncoMed Pharmaceuticals 62 Therapeutic Vaccines 62 Sinobiomed Inc. 62 Clearant Inc. 62 Ambit Biosciences 62 miRagen 62 bluebird bio 62 proprietary encapsulation 62 myeloproliferative disorders 62 pan HDAC inhibitor 62 LensAR 62 lixivaptan 62 Alethia Biotherapeutics 62 OTCBB INSV 62 Combivir Kivexa 62 proprietary PEGylation 62 Perlegen Sciences 62 Aegerion Pharmaceuticals 62 GTC NASDAQ GTCB 62 Nitec Pharma 62 Unit Dose Budesonide 62 Apricus Bio Nasdaq APRI 62 NASDAQ DRRX 62 BioSET 62 Ambrilia Biopharma 62 KL4 Surfactant 62 Immunex Corporation 62 Altus Pharmaceuticals 62 Alligator Bioscience 62 anticancer compounds 62 non nucleoside inhibitor 62 Luveris R Ovidrel R 62 Itero Biopharmaceuticals 62 Trubion Pharmaceuticals 62 Inc. dba Vitro 62 Anticancer Agent 62 MacroMed 62 Presents Positive 62 Enanta Pharmaceuticals 62 Dicerna Pharmaceuticals Inc. 62 Inovio Pharmaceuticals 62 novel immunotherapies 62 candidate epratuzumab 62 Optivia Biotechnology 62 IgG1 monoclonal antibody 62 NASDAQ DYAX 62 Ikaria Holdings Inc. 62 oral dual endothelin 62 Elvitegravir 62 Aflibercept 62 Vion Pharmaceuticals 62 TargeGen 62 Endotis 62 ARCA biopharma Inc. 62 developing Zerenex ferric 62 BioProcessors 62 Isotechnika Pharma 62 Nasdaq XTLB 62 Lexicon Genetics 62 AEMD 62 Viventia Biotech Inc. 61 Nuvera Biosciences 61 Acceleron Pharma 61 Fc fusion protein 61 Callisto Pharmaceuticals Inc. 61 novel antibody therapeutics 61 Insert Therapeutics 61 methylnaltrexone bromide 61 Bendamustine 61 Astellas Deutschland GmbH 61 acadesine 61 Protalix Biotherapeutics 61 Abbokinase 61 vivo validation 61 Isis Pharma 61 AngioChem 61 adult mesenchymal stem 61 Plexxikon 61 STO SOBI 61 JAK1 61 TRANSDUR ® 61 Kuvan TM sapropterin 61 PRNewswire FirstCall Nastech Pharmaceutical 61 vinca alkaloid 61 Marillion Pharmaceuticals 61 NASDAQ ARRY 61 QuantRx Biomedical Corporation 61 trastuzumab DM1 T DM1 61 Dr. Amnon Gonenne 61 Calando Pharmaceuticals Inc. 61 GVAX ® 61 OTCBB DORB 61 AVAX Technologies Inc. 61 Fludara ® 61 Gendux AB 61 AGY Therapeutics 61 AFFiRiS 61 HTS assay 61 Aileron Therapeutics 61 Therapeutic Competitors 61 Awarded Qualifying Therapeutic 61 Bionovo Inc. 61 OTCBB FCSC biotechnology 61 Cyntellect 61 Lipocine 61 Zenyaku Kogyo 61 MolecularMD 61 Bucindolol 61 Optimata 61 Ozarelix 61 epothilones 61 OncoGenex Pharmaceuticals Inc. 61 selective kinase inhibitor 61 Promedior 61 Bremelanotide 61 Duncan Higgons 61 Omacetaxine 61 J. Donald deBethizy 61 NASDAQ ALNY 61 CyDex Pharmaceuticals 61 cathepsin K inhibitor 61 David Aviezer 61 Preclinical Study 61 Kiadis Pharma 61 Avantra Biosciences 61 Anti VEGF 61 Stromedix 61 Tracon Pharmaceuticals 61 Immtech Pharmaceuticals Inc. 61 molecular chaperone regulation 61 Nanobody R 61 SABiosciences 61 Nasdaq LXRX biopharmaceutical 61 OTCQB ABPI 61 Transave 61 Astex Therapeutics 61 Gemin X 61 oncolytic virus therapies 61 Novosom AG 61 Akesis Pharmaceuticals 61 Anchor Therapeutics 61 Tranzyme 61 iCeutica 61 HuMax TAC 61 EyeGate Pharma 61 Genome Therapeutics 61 Inotek 61 Vicor Technologies 61 www.ucb group.com 61 Ph.D. Targacept 61 Nasdaq MYGN 61 Neosil 61 Azacitidine 61 EKR Therapeutics 61 Singulex 61 Psivida 61 Molecular Profiling 61 CureTech 61 Successfully Completes Phase 61 Stem Cell Innovations 61 SagaX 61 novel RNAi therapeutics 61 Argos Therapeutics 61 siRNA Delivery 61 Septin 9 61 Nexavar sorafenib 61 Lipid Sciences Inc. 61 Mirna Therapeutics 61 Antiangiogenic 61 AMEX DDD 61 Pancreate 61 Ventrus 61 Biolex Therapeutics 61 Hana Biosciences 61 Nutra Pharma Corporation 61 Locked Nucleic Acid LNA 61 IMiDs ® compound 61 PDE# inhibitors 61 Nasdaq DVAX 61 Tod Woolf Ph.D. 61 Vidaza R 61 AVEO Pharmaceuticals Inc. 61 Crucell NV NYSE Euronext 61 Veregen TM 61 Diasome 61 Semafore 61 Aegis Therapeutics 61 Inc. AMEX LIV 61 SomaLogic 61 Cordex Pharma 61 Recombinant Protein 61 Neuromed Pharmaceuticals Ltd. 61 Nanotherapeutics 61 HemaQuest 61 Phase 2b Clinical Trial 61 Loic Maurel 61 Inc. Nasdaq IMGN 61 aptamer therapeutics 61 Aposense Ltd. 61 Nanobac Pharmaceuticals 61 CoDa Therapeutics 61 Elusys 61 small molecule thrombopoietin 61 Pathway Diagnostics 61 RECOTHROM R 61 Regenerative Cells 61 Paradigm Genetics 61 Antisense 61 Maxy G# 61 JAK Inhibitor 61 Announce License Agreement 61 P#X# antagonist 61 Fumapharm 61 VaxInnate 61 TissueInformatics 61 JAK inhibitors 61 OTCBB AFLB 61 Vascugel 61 Cambria Biosciences 61 visit http:/www.mannkindcorp.com 61 IRX Therapeutics 61 COX Inhibiting Nitric Oxide 61 Cutanea 61 OSI Prosidion 61 Histogen 61 Fujisawa Healthcare Inc. 61 Aegerion 61 Keryx Biopharma 61 novel therapeutic antibodies 61 Tapestry Pharmaceuticals 61 Barry D. Quart 61 Alfacell proprietary ribonuclease 61 Igeneon 61 SAR# [002] 61 Pervasis Therapeutics 61 Sirona Biochem 61 GA GCB 61 HSP# inhibitors 61 sodium thiosulfate STS 61 ViroChem Pharma Inc. 61 GlycoMimetics 61 Cypress Bioscience Inc 61 mda 7 61 Lixivaptan 61 PregLem 61 faropenem 61 HQK 61 CellExSys 61 Upstream Biosciences 61 Attitude Drinks Inc. 61 Diabetic Neuropathy 61 Oxxon Therapeutics 61 Enobia 61 Sinobiomed 61 aTyr Pharma 61 miRNA therapeutics 61 MTP inhibitor 61 ONCONASE R 61 Bioservices 61 Nasdaq AVNC 61 HyACT 61 Lentigen 61 Oncobionic 61 Aegerion Pharmaceuticals Inc. 61 Inc. NASDAQ AEZS 61 Charlesson 61 Cellectricon 61 PRNewswire FirstCall Helix BioMedix 61 NeuroMedix 61 OTCBB OHRP 61 MediVas 61 Receives Orphan Drug 61 Ilypsa 61 MKC# MKC# PP 61 DiLA2 61 Nasdaq VRTX today 61 Radient Pharma 61 HXBM 61 JAK2 inhibitor 61 Regeneron Pharma 61 Daclizumab 61 MKC# MT 61 Coley Pharmaceutical Group 61 Infectech 61 TRAIL receptor antibodies 61 TOPIGEN 61 nicotinic alpha 7 61 NTDDS 61 Nasdaq EPCT 61 RhuDex 61 Novasys Medical Inc. 61 Nasdaq SPPI 61 Pink Sheets RHHBY